March 11 (Reuters) - AcouSort AB ACOUS.ST:
SAID ON TUESDAY SIGNED AMENDMENT TO ITS LICENSE AND DISTRIBUTION AGREEMENT WITH BLOOD-GAS ANALYZER COMPANY, WERFEN
UNDER THE AMENDMENT, WERFEN WILL PREPAY MINIMUM ROYALTIES FOR 2027 AND 2028
TOGETHER WITH WERFEN'S REGULAR 2026 MINIMUM ROYALTY, THE TOTAL SUM PAYABLE TO ACOUSORT IN EARLY 2026 AMOUNTS TO ABOUT USD 1.3 MILLION
Source text for Workspace: nMFN19jcmp
Further company coverage: ACOUS.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))